澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Entropy Neurodynamics Ltd

0.036

-0.002-5.26%

成交量：77.56万

成交额：2.80万

市值：5,871.83万

市盈率：-11.60

高：0.038

开：0.038

低：0.036

收：0.038

52周最高：0.043

52周最低：0.025

股本：16.31亿

流通股本：8.78亿

量比：0.49

换手率：0.09%

股息：- -

股息率：- -

每股收益(TTM):-0.003

每股收益(LYR):-0.003

净资产收益率：-73.07%

总资产收益率：-40.38%

市净率：7.97

市盈率(LYR):-11.61

数据加载中...

总览公司新闻资讯公告

熵神经动力学有限公司：本财务期内未派发、建议或宣派任何股息

Entropy Neurodynamics发布重大公告前停牌，涉及与Robin Carhart-Harris教授合作的美股二期临床试验

Entropy Neurodynamics Ltd - 协议为Trp-8803的全球开发与商业化奠定关键基石

Entropy Neurodynamics与TGA许可、FDA及EMA对齐的CDMO Biocina签署战略协议，生产TRP-8803

Entropy Neurodynamics携手斯威本科技大学，开启全球首创临床试验研究合作

Entropy Neurodynamics 拟在单一临床框架下评估 Trp-8803 对八大主要病症的疗效

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/ENP.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","market":"AU","secType":"STK","nameCN":"Entropy Neurodynamics Ltd","latestPrice":0.036,"timestamp":1791781920000,"preClose":0.038,"halted":0,"volume":775629,"delay":0,"changeRate":-0.05263157894736847,"nameEN":"Entropy Neurodynamics Ltd","floatShares":878046607,"shares":1631064683,"eps":-0.003104,"marketStatus":"未开盘","change":-0.002,"latestTime":"10-12 16:12:00 AEDT","open":0.038,"high":0.038,"low":0.036,"amount":27968,"amplitude":0.052632,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003104,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.038,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":0.4879215006195242,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ENP.AU","preClose":0.038,"auctionPrice":0.036,"auctionVolume":732,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781794475}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","floatShares":878046607,"roa":"-40.38%","roe":"-73.07%","lyrEps":-0.0031,"volumeRatio":0.4879215006195242,"shares":1631064683,"dividePrice":0,"high":0.038,"amplitude":0.052632,"preClose":0.038,"low":0.036,"week52Low":0.025,"pbRate":"7.97","psRate":"30.80","week52High":0.043,"institutionHeld":0,"latestPrice":0.036,"eps":-0.003104,"divideRate":0,"volume":775629,"delay":0,"ttmEps":-0.003104,"open":0.038,"prevYearClose":0.033,"prevWeekClose":0.038,"prevMonthClose":0.039,"prevQuarterClose":0.039,"fiveDayClose":0.04,"twentyDayClose":0.041,"sixtyDayClose":0.035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENP.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140171807","title":"熵神经动力学有限公司：本财务期内未派发、建议或宣派任何股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1140171807","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140171807?lang=zh_cn&edition=fundamental","pubTime":"2026-08-28 07:48","pubTimestamp":1787874489,"startTime":"0","endTime":"0","summary":"熵神经动力学有限公司（Entropy Neurodynamics Ltd）于当前财务期间，并未支付、建议或宣派任何形式的股息。这一决定，无疑向市场传递了该公司在资本配置策略上的审慎态度。投资者们，或许正密切关注着这家企业的现金流向与未来发展规划，但截至目前，股东们将不会收到任何分红回报。值得注意的是，公司此举可能意在将更多资金留存于内部，以支持其研发项目或潜在的业务扩张需求。然而，在缺乏明确指引的情况下，外界对其财务健康状况的猜测，恐怕也难以平息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154608676","title":"Entropy Neurodynamics发布重大公告前停牌，涉及与Robin Carhart-Harris教授合作的美股二期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1154608676","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154608676?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 07:41","pubTimestamp":1787528472,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics宣布停牌，等待发布一项重要公告。该公告内容与美国二期临床试验相关，此次试验是与Robin Carhart-Harris教授合作开展的。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127786328","title":"Entropy Neurodynamics Ltd - 协议为Trp-8803的全球开发与商业化奠定关键基石","url":"https://stock-news.laohu8.com/highlight/detail?id=1127786328","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127786328?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 06:22","pubTimestamp":1787091728,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Ltd - 该协议的签署，为Trp-8803在全球范围内的进一步开发与商业化推广，构筑了坚实而关键的基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157043905","title":"Entropy Neurodynamics与TGA许可、FDA及EMA对齐的CDMO Biocina签署战略协议，生产TRP-8803","url":"https://stock-news.laohu8.com/highlight/detail?id=1157043905","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157043905?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 06:21","pubTimestamp":1787091668,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Limited宣布，已与Biocina签署一项战略协议。Biocina是一家持有TGA许可、并符合FDA与EMA标准的合同开发与制造组织（CDMO）。根据协议，Biocina将负责生产TRP-8803。此举标志着Entropy Neurodynamics在神经动力学领域迈出关键一步，为其候选产品的商业化供应奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152849709","title":"Entropy Neurodynamics携手斯威本科技大学，开启全球首创临床试验研究合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1152849709","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152849709?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 22:14","pubTimestamp":1785852846,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics Limited已与斯威本科技大学正式签署临床试验研究协议。此举旨在推进一项全球首创的临床试验项目，标志着神经动力学领域的研究迈入全新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192195208","title":"Entropy Neurodynamics 拟在单一临床框架下评估 Trp-8803 对八大主要病症的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1192195208","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192195208?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 22:08","pubTimestamp":1785852503,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics 公司宣布，计划在独一的临床架构内，对旗下药物 Trp-8803 展开针对八种主要疾病的系统性评估。这一举措，旨在通过整合性的研究路径，高效地挖掘该候选药物的治疗潜力，从而为多种神经及相关疾病领域提供新的治疗方向。该研究框架的设计，力求实现跨疾病数据的同步收集与分析，以加速临床验证进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}